Why did SPL rise 18.1% on 11 Feb 2026?
Starpharma · Pharmaceuticals, Biotechnology & Life Sciences
What moved it
A substantial shareholding change announcement on the event date likely triggered investor interest, possibly indicating insider or activist accumulation.
The only company-specific news on the event date was a change in substantial holding, which can indicate buying or selling by a major shareholder and often moves the stock. Other articles are either about different companies or general sector pieces, and none directly explain the sharp price rise. The absence of any operational or financial announcement makes this the most plausible, albeit circumstantial, cause.
Written by a language model from the evidence below, and it can be wrong. Tell us and we will fix or remove it. General information only, not financial product advice.
The evidence
In the news
Weak Earnings Push ASX Biotech Giant to Multi-Year Lows: Can It Turn Things Around?
Kalkine · 11 Feb 2026
SPL:ASX Announcement - Change in substantial holding - 10 Feb 2026
Market Index · 10 Feb 2026
Is Graphene Technology Starting to Pay Off?
smallcaps.com.au · 12 Feb 2026
Pro Medicus (ASX:PME) Falls 15% on Thursday, Brokers Maintain Bullish Targets
Kalkine · 12 Feb 2026
The 4 most recent of 5 articles read. Headlines link to the publisher.
Held by no ETF
Not currently held by any ETF we track.